StockClub

AYTU

AYTUAytu BioPharma, Inc.$ --
Aytu BioPharma, Inc.

Aytu BioPharma, Inc.

AYTU

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2026 Q2
Revenue
15M USD
YoY -6.5%
Operating Income
-2M USD
YoY -16.2%
Net Income
-11M USD
YoY -1443.1%
EPS
-1.05$
YoY -5350.0%

Revenue

$29.1M
FY2024 Q3$50.6M
$50.6M
Q3
FY2024 Q4$68.6M
$68.6M
Q4
FY2025 Q1$16.6M
$16.6M
Q1
FY2025 Q2$32.8M
$32.8M
Q2
FY2025 Q3$51.2M
$51.2M
Q3
FY2025 Q4$66.4M
$66.4M
Q4
FY2026 Q1$13.9M
$13.9M
Q1
FY2026 Q2$29.1M
$29.1M
Q2
Actual
$-3.7M (-11.4%)

Net Income

$-8.6M
FY2024 Q3$-11.2M
$-11.2M
Q3
FY2024 Q4$-15.8M
$-15.8M
Q4
FY2025 Q1$1.5M
$1.5M
Q1
FY2025 Q2$2.3M
$2.3M
Q2
FY2025 Q3$6.3M
$6.3M
Q3
FY2025 Q4$-13.6M
$-13.6M
Q4
FY2026 Q1$2M
$2M
Q1
FY2026 Q2$-8.6M
$-8.6M
Q2
Actual
$-10.9M (-481.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$27.6M
Est:$24M
FY2020BEAT
$27.6M
FY2021MISS
Actual:$65.6M
Est:$66.2M
FY2021MISS
$65.6M
FY2022BEAT
Actual:$96.7M
Est:$94.9M
FY2022BEAT
$96.7M
FY2023BEAT
Actual:$107.4M
Est:$104.4M
FY2023BEAT
$107.4M
FY2024MISS
Actual:$65.2M
Est:$81.3M
FY2024MISS
$65.2M
FY2025MISS
Actual:$66.4M
Est:$69.2M
FY2025MISS
$66.4M

Analyst Estimates